Magnetic hybrid Pd/Fe-oxide nanoparticles meet the demands for ablative thermo-brachytherapy.

Palladium iron/oxide nanoparticles breast cancer magnetic hyperthermia thermal ablation thermo-brachytherapy

Journal

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
ISSN: 1464-5157
Titre abrégé: Int J Hyperthermia
Pays: England
ID NLM: 8508395

Informations de publication

Date de publication:
2024
Historique:
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: ppublish

Résumé

To investigate the potential of hybrid Pd/Fe-oxide magnetic nanoparticles designed for thermo-brachytherapy of breast cancer, considering their specific loss power ( Hybrid nanoparticles consisting of palladium-core and iron oxide shell of increasing thickness, were suspended in water and their Validation of the heating device used in this study with commercial HyperMag-C nanoparticles showed a small deviation (±4%) over a period of 1 year, confirming the reliability of the method. The integration of dual thermometers, one in the center and one at the bottom of the sample vial, allowed monitoring of homogeneity of the sample suspensions. Nanoparticles consisting of non-magnetic palladium-core and magnetic iron oxide shell are suitable for magnetic hyperthermia/thermal ablation under clinically safe conditions of 346 kHz and 19.1 mT, with minimal eddy current effects in combination with maximum

Identifiants

pubmed: 38189281
doi: 10.1080/02656736.2023.2299480
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2299480

Auteurs

Rogier van Oossanen (R)

Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
Department of Radiation Science and Technology, Delft University of Technology, Delft, The Netherlands.

Alexandra Maier (A)

Department of Biotechnology, Delft University of Technology, Delft, The Netherlands.

Jérémy Godart (J)

Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

Jean-Philippe Pignol (JP)

Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

Antonia G Denkova (AG)

Department of Radiation Science and Technology, Delft University of Technology, Delft, The Netherlands.

Gerard C van Rhoon (GC)

Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

Kristina Djanashvili (K)

Department of Biotechnology, Delft University of Technology, Delft, The Netherlands.

Classifications MeSH